OFI Invest Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

OFI Invest Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$320K	Buy	6,357 +915	+17%	+$52.5K	﹤0.01%	337
2026 Q1	$286K	Buy	5,442 +897	+20%	+$52.3K	﹤0.01%	307
2025 Q4	$209K	Buy	4,545 +1,717	+61%	+$82.6K	﹤0.01%	321
2025 Q3	$109K	Buy	2,828 +1,139	+67%	+$53.2K	﹤0.01%	256
2025 Q2	$66.6K	Buy	1,689 +426	+34%	+$20.9K	﹤0.01%	304
2025 Q1	$71.3K	Buy	1,263 +440	+53%	+$25.6K	﹤0.01%	285
2024 Q4	$45K	Buy	+823	New	+$46K	﹤0.01%	299
2024 Q2	$24.9K	Buy	642 +61	+10%	+$2.73K	﹤0.01%	361
2024 Q1	$29.2K	Buy	581 +133	+30%	+$6.78K	﹤0.01%	256
2023 Q4	$20.8K	Sell	448 -16	-3%	-$840	﹤0.01%	287
2023 Q3	$25.4K	Buy	+464	New	+$28.4K	﹤0.01%	192
2023 Q2	–	Sell	-329,222	Closed	-$4.75M	–	109
2023 Q1	$4.75M	Buy	+329,222	New	+$23.2M	0.02%	98

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

OFI Invest Asset Management's BMY Position: Q2 2026 in Review

OFI Invest Asset Management increased its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2026, buying an estimated $52.5K and bringing the position to 6,357 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #337.

OFI Invest Asset Management first reported a position in BMY in Q1 2023 and has held it in 12 quarters since. The position peaked at $4.75M in Q1 2023. 1,031 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

OFI Invest Asset Management held 6,357 shares of Bristol-Myers Squibb worth $320K as of Q2 2026.
OFI Invest Asset Management bought 915 Bristol-Myers Squibb shares in Q2 2026, an estimated $52.5K.
Bristol-Myers Squibb made up ﹤0.01% of OFI Invest Asset Management's portfolio in Q2 2026, its #337 holding.
OFI Invest Asset Management first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 12 quarters since.
OFI Invest Asset Management's Bristol-Myers Squibb position peaked at $4.75M in Q1 2023.
1,031 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.